This report presents findings on Johns Hopkins Hospital’s (JHH) practices in suing its patients for medical debt. Since 2009, JHH filed more than 2,400 lawsuits in Maryland courts seeking the repayment of $4.8 million in alleged medical debt from former patients, with a median amount of $1,438, based on review of thousands of electronic
Canada opposes any U.S. plans to buy Canadian prescription drugs that might threaten the country’s drug supply or raise costs for its own citizens, officials have told U.S. authorities, in a new setback to the Trump administration’s efforts to tackle high drug prices, according to documents obtained by Reuters.
A decade-old experiment to put a dent in Massachusetts health care costs by changing the way doctors are paid appears to be working — offering a potential strategy to combat one of the most vexing problems in today’s economy.
Cancer treatment has never been cheap. But in the pricey world of pharmaceuticals, the cost of oncology drugs has become jaw-dropping. And where there are big dollars, there is a battle between business interests, which is why cancer doctors are declaring war against pharmacy benefit managers.
Senate Finance Committee Republicans have yet to agree on their compromise package to lower drug prices, but Congressional Budget Office staffers estimated Wednesday that the bill would save money for both the government and Medicare beneficiaries.
The 340B program mandates that pharmaceutical manufacturers provide outpatient drugs to certain healthcare entities—known as eligible covered entities—at significant discounts. A covered entity can purchase and dispense 340B drugs through internal or external (contract) pharmacies.
Millions of Americans in high-deductible health plans may find it easier to access insulin, inhalers and other treatments for chronic health problems under guidance released Wednesday by the Trump administration.